User profiles for Varnavas Konstantinou

Varnavas Constantinou

Other name: Varnavas Konstantinou
Hematology Consultant - Transplant physician
Verified email at goc.com.cy
Cited by 811

Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for …

…, I Batsis, C Apostolou, V Konstantinou… - Leukemia & …, 2015 - Taylor & Francis
Optimal conditioning remains a challenge in lymphomas. We designed a regimen consisting
of Busulfex, etoposide and melphalan (BuEM). We retrospectively analyzed the outcome of …

Efficacy and Toxicity of Donor Lymphocyte Infusions in Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation: Single-Center …

I Sakellari, V Konstantinou, E Gavriilaki, D Mallouri… - 2016 - ashpublications.org
Introduction: Allogeneic hematopoietic cell transplantation (alloHCT) is a potentially curative
treatment in acute myeloid leukemia (AML) and is pursued as a means to decrease the …

Impaired Antibody RESPONSE FOLLOWING VACCINATION Against Hepatitis-B VIRUS In Autografted PATIENTS for Hematologic Malignancies: PRELIMINARY …

P Kaloyannidis, V Konstantinou, E Georgiadou… - Blood, 2011 - Elsevier
Abstract 1999 Infections are major barriers for a favorable outcome following stem cell
transplantation (SCT) and their prevention is a significant task in the clinical practice. Vaccinations …

Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in …

D Mallouri, I Sakellari, I Batsis, V Konstantinou… - Blood, 2010 - Elsevier
Abstract 1324 The standard conditioning regimen used in autologous hematopoietic cell
transplantation (autoHCT) for lymphomas is BEAM. During the last year, due to Carmustine (…

Matched Pair Analysis of Efficacy and Toxicity of Conditioning BEAM and Busilvex Based Regimen in Autologous Hematopoietic Cell Transplantation for Lymphomas …

…, D Sotiropoulos, I Batsis, V Konstantinou… - Biology of Blood and …, 2013 - tctjournal.org
The treatment of advanced and poor-risk multiple myeloma (MM) is still a major challenge
and no therapy has proven to be curative or effective long term. Although allogeneic HCT has …

Donor Lymphocyte Infusions' Efficacy in Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation: A Single Center Long-Term Analysis

…, I Sakellari, E Gavriilaki, V Konstantinou… - Biology of Blood and …, 2017 - tctjournal.org
Background: Relapse after hematopoietic stem cell transplant (HSCT) for pediatric leukemia
has poor prognosis. However as persistent mixed chimerism (MC) is a known predictor of …

Immunogenetic Cross-Talk in Patients Transplanted for AML: CMV Reactivation Is Not a Strong Stimulus for Immune Response Against Leukemia

…, P Zerva, T Touloumenidou, V Konstantinou… - Biology of Blood and …, 2015 - tctjournal.org
Methods: We studied outcomes in a cohort of 105 consecutive ex vivo T cell depleted (TCD)
allogeneic transplants from 6/6 HLA-matched sibling donors between 2006e2014. …

Transplant-Associated Thrombotic Microangiopathy: Prevalence, Prognostic Factors and Treatment Outcomes in Unrelated Allogeneic Transplant for Hematologic …

…, I Batsis, Z Boussiouu, D Mallouri, V Konstantinou… - 2016 - ashpublications.org
Introduction: Transplant-associated thrombotic microangiopathy (TA-TMA) represents a
devastating and life-threatening complication occurring more frequently in allogeneic compared …

Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies

…, D Mallouri, Z Bousiou, V Konstantinou… - European …, 2014 - Eur Respiratory Soc
Background:Allogeneic hematopoietic stem cell transplantation (alloHCT) may be
accompanied with severe pulmonary complications with the deterioration of pulmonary function …

A matched pair analysis of conditioning BuEM versus BEAM in autologous haematopoietic cell transplantation for lymphomas in terms of toxicity and efficacy.

…, D Mallouri, I Batsis, C Apostolou, V Konstantinou… - 2013 - ascopubs.org
8567 Background: In autologous hematopoietic cell transplantation (AHCT) for lymphomas,
the optimal conditioning regimen is currently investigated. The standard conditioning used is …